Recent years have witnessed remarkable progresses in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://jayanyzy811733.blogadvize.com/47151157/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements